3994-11-4

Basic information

• Product Name: (S)-alpha-methylphenethylammonium [R-(R*,R*)]-hydrogen tartrate
• Synonyms: (S)-alpha-methylphenethylammonium [R-(R*,R*)]-hydrogen tartrate;DELTA-AMPHETAMIDETARTRATE;d-Amphetamine tartrate;Dextroamphetamine tartrate;Maxiton
• CAS NO: 3994-11-4
• Molecular Formula: C₄H₆O₆*C₉H₁₃N
• Molecular Weight: 285.29306
• EINECS: 223-642-5
• Mol File: 3994-11-4.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 209.3°Cat760mmHg
• Flash Point: 84.6°C
• Appearance: /
• Density: g/cm³
• Vapor Pressure: 0.204mmHg at 25°C
• CAS DataBase Reference: (S)-alpha-methylphenethylammonium [R-(R*,R*)]-hydrogen tartrate(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-alpha-methylphenethylammonium [R-(R*,R*)]-hydrogen tartrate(3994-11-4)
• EPA Substance Registry System: (S)-alpha-methylphenethylammonium [R-(R*,R*)]-hydrogen tartrate(3994-11-4)

Safety Data

• Hazardous Substances Data: 3994-11-4(Hazardous Substances Data)

Usage

Description

(S)-alpha-methylphenethylammonium [R-(R,R)]-hydrogen tartrate is a chemical compound derived from (S)-alpha-methylphenethylamine, a central nervous system stimulant, and hydrogen tartrate. It has potential pharmaceutical applications and is currently under investigation for its therapeutic uses and mechanisms of action. The R-enantiomer of this compound is considered to have greater pharmacological activity than the S-enantiomer.

Uses

Used in Pharmaceutical Industry:
(S)-alpha-methylphenethylammonium [R-(R,R)]-hydrogen tartrate is used as a potential treatment for attention deficit hyperactivity disorder (ADHD) due to its stimulant properties, which can help improve focus and reduce hyperactivity in affected individuals.
(S)-alpha-methylphenethylammonium [R-(R,R)]-hydrogen tartrate is also used as a potential treatment for narcolepsy, a sleep disorder characterized by excessive daytime sleepiness and sudden attacks of sleep. Its stimulant effects may help alleviate these symptoms and improve the quality of life for patients.
Additionally, (S)-alpha-methylphenethylammonium [R-(R,R)]-hydrogen tartrate is used as a potential weight loss medication. Its stimulant properties may contribute to increased metabolism and energy expenditure, which could aid in weight management and reduction.
Research on this compound is ongoing, and its potential therapeutic uses and mechanisms of action are being explored further to better understand its efficacy and safety in various medical applications.

InChI:InChI=1/C9H13N.C4H6O6/c1-7-5-3-4-6-9(7)8(2)10;5-1(3(7)8)2(6)4(9)10/h3-6,8H,10H2,1-2H3;1-2,5-6H,(H,7,8)(H,9,10)/t8-;1-,2-/m01/s1